All 26 received psychotherapy throughout the drug trial, and did not know what dose they were receiving. A month after their second dose, 86 percent of the 75 mg group no longer met the diagnostic criteria for PTSD, said the study authors. Too soon to tellDuring the trial, 85 "adverse events" -- including anxiety, headaches, fatigue, and insomnia -- were reported by 20 trial participants. Previous research has shown that MDMA helps relieve PTSD symptoms in victims of sexual crimes. "The unmet need for better PTSD treatment, particularly in veterans and first responders, is undoubted," they added.

Source: The Nation Bangkok May 01, 2018 22:41 UTC